Breaking News

ProBio Launches cGMP AAV Manufacturing Services at Hopewell, NJ Facility

Strategic expansion is designed to advance gene therapy development and manufacturing.

Author Image

By: Charlie Sternberg

Associate Editor

ProBio, a contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, has launched cGMP Adeno-Associated Virus (AAV) manufacturing services at its 128,000 sq. ft. facility in Hopewell, New Jersey. The Hopewell facility is purpose-built to provide end-to-end AAV manufacturing solutions that align with global regulatory and quality standards. ProBio’s new capabilities offer clients fully integrated services—including GMP plasmid DNA production, AAV ve...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters